To: Cryer Solutions
From: Kimiko Kurutsuki, VP of R&D of Kishiro Technologies
Re: Psionic Jump Drive Potential
Encryption: Re encryption every 15 seconds utilizing terabit encryption with seed generation based on time interval between sender's breaths and eye blinks multiplied together during transmission.
Re: Liquid Cardamine Research
Recent events have caused me to become curious about the information available on cardamine without propaganda of those in favor of its use and those against it. I just want facts about what it does to the human body. What it can and can't do and why specifically it does. There are plenty of rumors, and with my focus on physics, I will understand that more. I have had some thoughts concerning it after a dream suggested that a modified form of it would make it possible for a ship to have a kind of psionic jump drive.. This has caused me some excitement.
I will happily arrange contracts if you can provide the information I require. Perhaps our companies together can arrive at a rather lucrative arrangement that will also better humanity.
Allow me to introduce myself. I am Doctor William Hudson, the CEO of Cryer Solutions. We handle all sorts of medical needs, ranging from visual enchancements and corrections, to healing all sorts of diseases, including the Cardamine affliction, as I like to call it.
I must regret to inform you, that research concerning Cardamine is considered classified and is being strictly regulated, to prevent abuse and also our competitors, from gaining the knowledge we have fought so hard to obtain.
As I can see, you wish to obtain knowledge about certain aspects of the drug, which could, or could not enchance the users psionic abilities, for the use in jump drive technology? Since that is not our area of expertise, I doubt that we would be of much use to you.
What I am prepared to do though, is offer you an invitation to our research station, which is located somewhere in the Sigma systems. Just tell me where you would like to meet and I will arrange for an escort to wait for you there.
I must inform you at this time, that you will have to sign a non disclousure agreement, so all knowledge concerning the drug will have to be kept to yourself and all advancement that you make, that involves our research, will need to carry the "Cryer Solutions partial patent holder" status with it.
I am looking forward to your reply
Doctor William Hudson M.D.,
Vice President of Cryer Solutions.